$PMHS
Polomar Health Services, Inc.

2024 Q1 Form 10-Q Financial Statement

#000149315224019688 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $69.02K $18.41K $89.81K
YoY Change -23.15%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $69.02K $18.40K $89.81K
YoY Change -23.14%
Operating Profit -$69.02K -$18.40K -$89.81K
YoY Change -23.14%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$69.02K -$127.6K -$89.81K
YoY Change -23.15%
Income Tax
% Of Pretax Income
Net Earnings -$69.02K -$127.6K -$89.81K
YoY Change -23.14% 3891.38%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 109.1M shares 109.1M shares 108.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $240.00 $240.00 $198.3K
YoY Change -99.88%
Cash & Equivalents $244.00 $224.00 $198.3K
Short-Term Investments
Other Short-Term Assets $0.00 $4.060K
YoY Change
Inventory $3.459K
Prepaid Expenses
Receivables $20.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $244.00 $244.00 $222.4K
YoY Change -99.89% -99.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $94.83K
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $244.00 $244.00 $222.4K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $244.00 $244.00 $222.4K
YoY Change -99.89% -99.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.68K $13.78K $9.980K
YoY Change 197.39%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $53.13K $0.00 $5.250K
YoY Change 912.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $82.81K $13.78K $15.24K
YoY Change 443.35% -81.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $82.81K $13.78K $15.24K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $82.81K $13.78K $15.24K
YoY Change 443.35% -81.55%
SHAREHOLDERS EQUITY
Retained Earnings -$1.467M -$1.398M
YoY Change 42.42%
Common Stock $109.1K $109.1K
YoY Change 1.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$82.56K -$13.54K $207.2K
YoY Change
Total Liabilities & Shareholders Equity $244.00 $244.00 $222.4K
YoY Change -99.89% -99.91%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023 Q1
OPERATING ACTIVITIES
Net Income -$69.02K -$127.6K -$89.81K
YoY Change -23.14% 3891.38%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.14K $537.4K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.700K -556.6K
YoY Change
NET CHANGE
Cash From Operating Activities -10.14K 537.4K
Cash From Investing Activities
Cash From Financing Activities -4.700K -556.6K
Net Change In Cash -14.84K -19.21K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$10.14K $537.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Gross Profit
GrossProfit
usd
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 705
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90024
CY2024Q1 dei City Area Code
CityAreaCode
(213)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
616-0011
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001265521
CY2023Q1 us-gaap Gross Profit
GrossProfit
usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2024Q1 us-gaap Interest Paid
InterestPaid
usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-56555
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Trustfeed Corp.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1006313
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10940 Wilshire Blvd
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109138049 shares
CY2024Q1 us-gaap Cash
Cash
244 usd
CY2023Q4 us-gaap Cash
Cash
244 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
244 usd
CY2024Q1 us-gaap Assets
Assets
244 usd
CY2023Q4 us-gaap Assets
Assets
244 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
29682 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13782 usd
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
53125 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
82807 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13782 usd
CY2024Q1 us-gaap Liabilities
Liabilities
82807 usd
CY2023Q4 us-gaap Liabilities
Liabilities
13782 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109138049 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109138049 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108517979 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108517979 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
109138 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
109138 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1275156 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1275156 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1467357 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1398333 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-82563 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-13539 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
244 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
69024 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
89806 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
69024 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
89806 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-69024 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-89806 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-69024 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-89806 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0006
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0006
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0008
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0008
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109138049 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108517979 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
186769 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110192 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-89806 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
207155 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-90958 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
116197 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2142 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-13539 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-13539 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-69024 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-82563 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-82563 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-69024 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-89806 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1810 usd
CY2024Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-53125 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15899 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4970 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-73026 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
110192 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
550 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
65000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45742 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27284 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
244 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
225619 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
244 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
198335 usd
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2000-09-14
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse split in which each shareholder was issued one common share in exchange for every two thousand common shares of their then-currently issued common stock
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
266157 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
266157 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zXt9RjpgjW5e" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zrPUyMkfwA6f">Use of estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-69024 usd
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1467357 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
295000000 shares
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On June 3, 2023, the Board authorized the execution of a reverse split of the issued and outstanding shares of the Corporation’s common stock at a ratio of up to one post-split share per two thousand pre-split shares (1:2,000)
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109138049 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108517979 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0006
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0008
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares

Files In Submission

Name View Source Status
0001493152-24-019688-index-headers.html Edgar Link pending
0001493152-24-019688-index.html Edgar Link pending
0001493152-24-019688.txt Edgar Link pending
0001493152-24-019688-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trfe-20240331.xsd Edgar Link pending
trfe-20240331_cal.xml Edgar Link unprocessable
trfe-20240331_def.xml Edgar Link unprocessable
trfe-20240331_lab.xml Edgar Link unprocessable
trfe-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable